-
Reteplase,
trade names include Retavase, is a
thrombolytic drug, used to
treat heart attacks by
breaking up the
clots that
cause them.
Reteplase is a recombinant...
-
blood clots.
These medications include tissue plasminogen activator,
reteplase, streptokinase, and tenecteplase.
Thrombolysis is not
recommended in a...
- of
recombinant tissue plasminogen activator (rtPA) such as alteplase,
reteplase, and tenecteplase.
These drugs are used in
clinical medicine to treat...
-
thrombolysis (clot dissolution) by
thrombolytic medications (e.g., alteplase,
reteplase), as
either alternative or
complement thereto. It is
commonly performed...
- alteplase,
reteplase, and tenecteplase.
Alteplase was the
first of
these versions to go on the market, and has the same
exact structure as tPA.
Reteplase and...
-
tissue plasminogen activators (rtPA)
Alteplase (Activase or Actilyse)
Reteplase (Retavase)
Tenecteplase Anistreplase (Eminase) In
people who
receive thrombolytic...
-
Novel alternatives to
treat catheter occlusion, such as tenecteplase,
reteplase, and
recombinant urokinase,
offer the
advantage of
shorter dwell times...
-
approach are the
expression of
reteplase in E.Coli and the
functional expression of
single chain Fv
antibodies in E. Coli
Reteplase is used in the treatment...
- "The platelet-related
effects of
tenecteplase versus alteplase versus reteplase".
Blood Coagulation & Fibrinolysis. 16 (1): 1–7. doi:10.1097/00001721-200501000-00001...
-
retapamulin (USAN)
retaspimycin (USAN, INN)
Retavase retelliptine (INN)
reteplase (INN)
Retet retigabine (INN) Retin-A
retinol (INN)
Retinova retosiban...
